Market Summary
USD84.96-0.01
Market Closed-0.01%
IRTC Alerts
IRTC Stock Price
IRTC RSI Chart
IRTC Valuation
IRTC Price/Sales (Trailing)
IRTC Profitability
IRTC Fundamentals
IRTC Revenue
IRTC Earnings
Price Action
52 Week Range
82.51140.23
(Low)(High)
Last 7 days
-9.1%
Last 30 days
-18.6%
Last 90 days
-15.8%
Trailing 12 Months
-28.7%
IRTC Financial Health
IRTC Investor Care
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
Get all data in R, Python etc through our Historical Stock Data APIs
Latest Insider Trading transactions for IRTC
Filter Transactions| Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
|---|---|---|---|---|---|---|
2023-08-09 | Bobzien Brice | sold | -150,909 | 111 | -1,356 | chief financial officer |
2023-08-03 | Day Mark J. | acquired | 17,602 | 36.22 | 486 | chief technology officer |
2023-08-02 | Patterson Chad | sold | -190,529 | 100 | -1,896 | chief commercial officer |
2023-07-03 | Turakhia Minang | sold | -102,238 | 103 | -988 | evp, cmo & cso |
2023-07-03 | Wilson Daniel G. | sold | -154,185 | 103 | -1,490 | evp, corp dev inv rel |
2023-06-06 | Blackford Quentin S. | acquired | 997,644 | 102 | 9,755 | president and ceo |
2023-06-02 | Shrishrimal Sumi | sold | -123,598 | 111 | -1,109 | evp, chief risk officer |
2023-06-01 | YOOR BRIAN B | acquired | - | - | 2,399 | - |
2023-06-01 | Poul Mojdeh | acquired | - | - | 2,399 | - |
2023-05-31 | Bairey Merz Cathleen Noel | back to issuer | -60,387 | 118 | -509 | - |
Which funds bought or sold IRTC recently?
View All Details| Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
|---|---|---|---|---|---|---|
2023-09-20 | BARCLAYS PLC | added | 31.73 | 203,000 | 2,097,000 | -% |
2023-08-25 | Yarbrough Capital, LLC | unchanged | - | -60,904 | 322,349 | 0.02% |
2023-08-24 | Alberta Investment Management Corp | unchanged | - | -1,866,810 | 9,880,560 | 0.10% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | sold off | -100 | -409,299 | - | -% |
2023-08-22 | COMERICA BANK | new | - | 76,000 | 76,000 | 0.01% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -1.75 | -811,549 | 3,861,400 | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -27.76 | -124,861 | 193,253 | -% |
2023-08-17 | Orion Portfolio Solutions, LLC | reduced | -43.13 | -1,376,020 | 1,261,860 | 0.01% |
2023-08-16 | Nuveen Asset Management, LLC | reduced | -18.61 | -4,044,290 | 8,775,710 | -% |
2023-08-15 | EVENTIDE ASSET MANAGEMENT, LLC | unchanged | - | -4,713,350 | 24,946,600 | 0.42% |
Latest Funds Activity
Calls
Puts
Net Call Options
No. of Funds
IRTC Alerts
Schedule 13G FIlings of Irhythm Tech
| Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
|---|---|---|---|---|---|
| Feb 14, 2023 | sands capital management, llc | 9.1% | 2,667,428 | SC 13G/A | |
| Feb 09, 2023 | vanguard group inc | 9.55% | 2,876,849 | SC 13G/A | |
| Jan 31, 2023 | blackrock inc. | 7.6% | 2,288,507 | SC 13G/A | |
| Jan 27, 2023 | mackenzie financial corp | 4.14% | 1,246,524 | SC 13G/A | |
| Feb 14, 2022 | sands capital management, llc | 10.34% | 3,041,867 | SC 13G/A | |
| Feb 14, 2022 | price t rowe associates inc /md/ | 1.7% | 524,505 | SC 13G/A | |
| Feb 04, 2022 | mackenzie financial corp | 5.73% | 1,685,430 | SC 13G/A | |
| Feb 03, 2022 | blackrock inc. | 7.1% | 2,084,707 | SC 13G/A | |
| Jan 24, 2022 | jpmorgan chase & co | 7.0% | 2,083,625 | SC 13G | |
| Jul 09, 2021 | brown capital management llc | 0% | 0 | SC 13G/A |
Recent SEC filings of Irhythm Tech
View All Filings| Date Filed | Form Type | Document | |
|---|---|---|---|
| Aug 18, 2023 | 3 | Insider Trading | |
| Aug 16, 2023 | 4/A | Insider Trading | |
| Aug 16, 2023 | 4/A | Insider Trading | |
| Aug 16, 2023 | 4/A | Insider Trading | |
| Aug 16, 2023 | 4/A | Insider Trading | |
| Aug 16, 2023 | 4/A | Insider Trading | |
| Aug 16, 2023 | 4/A | Insider Trading | |
| Aug 15, 2023 | 8-K | Current Report | |
| Aug 15, 2023 | 3 | Insider Trading | |
| Aug 10, 2023 | 4 | Insider Trading |
Peers (Alternatives to Irhythm Tech)
View All Peers In Detail| Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|
| LARGE-CAP | ||||||||
SYK | 103.9B | 19.5B | -1.64% | 35.04% | 38.34 | 5.34 | 10.36% | 30.30% |
ISRG | 102.1B | 6.7B | -2.29% | 54.71% | 71.68 | 15.33 | 11.75% | -0.66% |
BSX | 76.4B | 13.4B | 4.08% | 37.72% | 83.77 | 5.7 | 8.69% | 3.17% |
BDX | 71.3B | 19.0B | -6.81% | 13.51% | 44.09 | 3.79 | 0.46% | -5.24% |
EW | 42.8B | 5.7B | -7.61% | -15.82% | 30.79 | 7.56 | 5.64% | -4.53% |
| MID-CAP | ||||||||
PEN | 9.4B | 937.8M | -2.31% | 34.57% | 323.13 | 10.04 | 16.30% | 250.21% |
SWAV | 7.2B | 616.6M | -8.54% | -23.02% | 29.49 | 11.66 | 69.52% | 343.68% |
GMED | 5.0B | 1.1B | -9.61% | -15.17% | 23.63 | 4.53 | 12.63% | 50.85% |
IRTC | 2.6B | 452.1M | -18.56% | -28.66% | -26.15 | 5.74 | 24.99% | 24.09% |
TNDM | 1.4B | 790.3M | -22.43% | -53.70% | -6.08 | 1.73 | 3.21% | -1604.53% |
| SMALL-CAP | ||||||||
ATEC | 1.5B | 421.8M | -14.76% | 54.69% | -9.15 | 3.62 | 44.49% | -2.43% |
AVNS | 953.5M | 780.7M | -5.52% | -6.22% | -26.49 | 1.22 | 4.68% | -510.17% |
CSII | 839.3M | 239.8M | 0.70% | 0.15% | -22.16 | 3.5 | -4.74% | -31.15% |
SILK | 608.6M | 162.9M | -22.30% | -62.37% | -11.51 | 3.74 | 42.67% | 12.82% |
Irhythm Tech News
Returns for IRTC
Cumulative Returns on IRTC
-2.2%
5-Year Cumulative Returns
-27.9%
3-Year Cumulative Returns
Risks for IRTC
What is the probability of a big loss on IRTC?
100%
Probability that Irhythm Tech stock will be more than 20% underwater in next one year
82.3%
Probability that Irhythm Tech stock will be more than 30% underwater in next one year.
39.6%
Probability that Irhythm Tech stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.
How does IRTC drawdown profile look like?
Y-axis is the maximum loss one would have experienced if Irhythm Tech was unfortunately bought at previous high price.
Drawdowns
Financials for Irhythm Tech
Income Statement (Last 12 Months)
| Income Statement (Last 12 Months) | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Revenue | 5.1% | 452,058,000 | 429,979,000 | 410,921,000 | 380,108,000 | 361,665,000 | 340,892,000 | 322,825,000 | 319,830,000 | 306,342,000 | 275,942,000 | 265,166,000 | 245,461,000 | 228,190,000 | 229,753,000 | 214,552,000 | 197,230,000 | 180,998,000 | 163,849,000 | 147,277,000 | 133,678,000 | 120,272,000 |
| Gross Profit | 5.4% | 311,534,000 | 295,554,000 | 281,632,000 | 254,208,000 | 239,435,000 | 224,473,000 | 213,567,000 | 220,595,000 | 218,159,000 | 198,270,000 | 194,889,000 | 181,767,000 | 168,943,000 | 172,978,000 | 162,067,000 | 147,854,000 | 135,454,000 | 121,831,000 | 108,482,000 | 97,982,000 | 87,609,000 |
| Operating Expenses | 2.8% | 411,694,000 | 400,293,000 | 395,416,000 | 379,493,000 | 366,916,000 | 345,495,000 | 313,510,000 | 297,920,000 | 276,959,000 | 260,240,000 | 238,562,000 | 233,585,000 | 234,264,000 | 228,702,000 | 216,822,000 | 197,974,000 | 176,535,000 | 165,128,000 | 154,173,000 | 141,649,000 | 128,038,000 |
| S&GA Expenses | 2.8% | 359,052,000 | 349,383,000 | 322,198,000 | 307,080,000 | 297,266,000 | 278,184,000 | 274,839,000 | 259,515,000 | 238,471,000 | 218,816,000 | 197,233,000 | 194,592,000 | 190,540,000 | 189,687,000 | 179,523,000 | 162,859,000 | 149,833,000 | 141,612,000 | 133,313,000 | 123,795,000 | 111,480,000 |
| R&D Expenses | 3.4% | 52,642,000 | 50,910,000 | 46,610,000 | 45,805,000 | 43,042,000 | 40,703,000 | 38,671,000 | 38,405,000 | 38,488,000 | 41,424,000 | 41,329,000 | 38,993,000 | 43,724,000 | 39,015,000 | 37,299,000 | 35,115,000 | 26,702,000 | 23,516,000 | 20,860,000 | 17,854,000 | 16,558,000 |
| EBITDA | 100.0% | - | -87,406,000 | -98,343,000 | -111,816,000 | -115,310,000 | -110,108,000 | -89,983,000 | -68,206,000 | -49,836,000 | -53,482,000 | -35,182,000 | -43,590,000 | -58,066,000 | -49,311,000 | -49,415,000 | - | - | - | - | - | - |
| EBITDA Margin | 100.0% | - | -0.20 | -0.24 | -0.29 | -0.32 | -0.32 | -0.28 | -0.21 | -0.16 | -0.19 | -0.13 | -0.18 | -0.25 | -0.21 | -0.23 | - | - | - | - | - | - |
| Interest Expenses | 11.4% | 3,409,000 | 3,059,000 | 4,138,000 | 3,373,000 | 3,038,000 | 2,863,000 | 1,169,000 | 1,295,000 | 1,400,000 | 1,474,000 | 1,519,000 | 1,530,000 | 1,555,000 | 1,614,000 | 1,643,000 | 1,793,000 | 2,245,000 | 2,666,000 | 3,115,000 | 3,444,000 | 3,445,000 |
| Earnings Before Taxes | 5.4% | -98,751,000 | -104,346,000 | -115,886,000 | -128,193,000 | -130,495,000 | -123,875,000 | -100,994,000 | -78,237,000 | -59,172,000 | -62,234,000 | -43,601,000 | -51,208,000 | -64,909,000 | -55,313,000 | -54,503,000 | -53,447,000 | -44,901,000 | -46,397,000 | -50,334,000 | -44,066,666 | -46,646,000 |
| EBT Margin | 100.0% | - | -0.24 | -0.28 | -0.34 | -0.36 | -0.36 | -0.31 | -0.24 | -0.19 | -0.23 | -0.16 | -0.21 | -0.28 | -0.24 | -0.25 | - | - | - | - | - | - |
| Net Income | 5.2% | -99,240,000 | -104,655,000 | -116,155,000 | -128,448,000 | -130,728,000 | -124,191,000 | -101,361,000 | -78,521,000 | -59,467,000 | -62,544,000 | -43,830,000 | -51,479,000 | -65,095,000 | -55,383,000 | -54,568,000 | -53,538,000 | -44,972,000 | -47,551,000 | -50,378,000 | -45,257,000 | -42,054,000 |
| Net Income Margin | 100.0% | - | -0.24 | -0.28 | -0.34 | -0.36 | -0.36 | -0.31 | -0.25 | -0.19 | -0.23 | -0.17 | -0.21 | -0.29 | -0.24 | -0.25 | - | - | - | - | - | - |
| Free Cashflow | 100.0% | - | -47,561,000 | -52,842,000 | -75,995,000 | -68,962,000 | -64,224,000 | -65,820,000 | -42,696,000 | -41,724,000 | -47,592,000 | -27,310,000 | -49,441,000 | -59,815,000 | -49,223,000 | -42,320,000 | - | - | - | - | - | - |
Balance Sheet(In Millions)
| Balance Sheet | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Assets | 1.8% | 429 | 422 | 448 | 440 | 436 | 429 | 463 | 480 | 485 | 478 | 512 | 497 | 276 | 283 | 306 | 310 | 205 | 115 | 118 | 118 | 120 |
| Current Assets | -4.6% | 242 | 254 | 289 | 286 | 285 | 286 | 306 | 325 | 336 | 336 | 378 | 366 | 147 | 154 | 173 | 185 | 92.00 | 92.00 | 104 | 106 | 109 |
| Cash Equivalents | 16.6% | 62.00 | 53.00 | 79.00 | 71.00 | 101 | 95.00 | 128 | 167 | 139 | 137 | 89.00 | 95.00 | 82.00 | 57.00 | 20.00 | 35.00 | 16.00 | 28.00 | 20.00 | 17.00 | 19.00 |
| Inventory | -11.7% | 14.00 | 16.00 | 15.00 | 14.00 | 14.00 | 12.00 | 10.00 | 10.00 | 9.00 | 7.00 | 5.00 | 5.00 | 5.00 | 4.00 | 4.00 | 3.00 | 3.00 | 3.00 | 2.00 | 2.00 | 2.00 |
| Net PPE | 9.3% | 90.00 | 82.00 | 76.00 | 72.00 | 66.00 | 57.00 | 56.00 | 53.00 | 47.00 | 37.00 | 34.00 | 33.00 | 30.00 | 28.00 | 26.00 | 18.00 | 13.00 | 10.00 | 9.00 | 8.00 | 8.00 |
| Goodwill | 0% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Liabilities | 2.9% | 206 | 200 | 208 | 201 | 191 | 184 | 183 | 184 | 179 | 169 | 170 | 163 | 158 | 158 | 171 | 167 | 159 | 68.00 | 65.00 | 55.00 | 53.00 |
| Current Liabilities | 9.2% | 89.00 | 82.00 | 89.00 | 84.00 | 70.00 | 62.00 | 88.00 | 83.00 | 73.00 | 59.00 | 66.00 | 56.00 | 47.00 | 43.00 | 52.00 | 45.00 | 35.00 | 29.00 | 30.00 | 23.00 | 20.00 |
| Long Term Debt | - | - | - | - | - | - | - | 10.00 | - | - | - | 21.00 | - | - | - | 33.00 | - | - | - | 35.00 | - | - |
| LT Debt, Non Current | 0.0% | 35.00 | 35.00 | 35.00 | 35.00 | 35.00 | 35.00 | 10.00 | 13.00 | 16.00 | 18.00 | 21.00 | 24.00 | 27.00 | 30.00 | 33.00 | 35.00 | 35.00 | 35.00 | 35.00 | 33.00 | 33.00 |
| Shareholder's Equity | 0.9% | 224 | 222 | 240 | 239 | 245 | 245 | 280 | 296 | 306 | 310 | 342 | 335 | 118 | 125 | 135 | 143 | 47.00 | 48.00 | 52.00 | 63.00 | 67.00 |
| Retained Earnings | -3.3% | -579 | -561 | -522 | -502 | -480 | -456 | -406 | -373 | -349 | -332 | -304 | -295 | -290 | -269 | -260 | -243 | -224 | -214 | -205 | -189 | -179 |
| Additional Paid-In Capital | 2.6% | 804 | 783 | 762 | 742 | 726 | 702 | 686 | 669 | 656 | 642 | 646 | 629 | 408 | 395 | 396 | 386 | 271 | 262 | 258 | 253 | 247 |
| Shares Outstanding | 0.3% | 31.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 29.00 | 29.00 | 29.00 | 29.00 | 29.00 | 28.00 | 27.00 | 27.00 | 27.00 | 25.00 | 25.00 | 24.00 | 24.00 | 24.00 | 24.00 |
Cashflow (Last 12 Months)(In Millions)
| Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
| Cashflow From Operations | -28.2% | -19.08 | -14.88 | -23.01 | -48.63 | -34.62 | -34.80 | -37.75 | -16.89 | -23.62 | -33.23 | -13.76 | -26.44 | -38.24 | -27.07 | -21.86 | -21.38 | -25.61 | -33.00 | -29.09 | -28.44 | -27.13 |
| Share Based Compensation | -1.6% | 61.00 | 62.00 | 58.00 | 54.00 | 53.00 | 48.00 | 55.00 | 57.00 | 62.00 | 61.00 | 42.00 | 35.00 | 25.00 | 22.00 | 26.00 | 24.00 | 21.00 | 18.00 | 16.00 | 14.00 | 13.00 |
| Cashflow From Investing | 23.5% | -30.65 | -40.09 | -52.43 | -71.45 | -22.43 | -20.30 | 105 | 115 | -103 | -75.27 | -132 | -127 | -10.00 | -55.74 | -89.27 | -72.47 | 16.00 | 39.00 | 34.00 | 19.00 | 24.00 |
| Cashflow From Financing | -22.2% | 10.00 | 13.00 | 27.00 | 24.00 | 19.00 | 13.00 | -28.58 | -25.99 | 184 | 189 | 214 | 215 | 114 | 111 | 112 | 111 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 |
IRTC Income Statement
2023-06-30Condensed Consolidated Statements of Operations - USD ($) shares in Thousands | 3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
| Income Statement [Abstract] | ||||
| Revenue, net | $ 124,130,000 | $ 102,051,000 | $ 235,566,000 | $ 194,429,000 |
| Cost of revenue | 37,905,000 | 31,806,000 | 73,660,000 | 62,425,000 |
| Gross profit | 86,225,000 | 70,245,000 | 161,906,000 | 132,004,000 |
| Operating expenses: | ||||
| Research and development | 13,677,000 | 11,945,000 | 28,519,000 | 22,487,000 |
| Selling, general and administrative | 91,420,000 | 81,751,000 | 191,763,000 | 154,909,000 |
| Impairment and restructuring charges | 0 | 0 | 0 | 26,608,000 |
| Total operating expenses | 105,097,000 | 93,696,000 | 220,282,000 | 204,004,000 |
| Loss from operations | (18,872,000) | (23,451,000) | (58,376,000) | (72,000,000) |
| Interest expense | (832,000) | (482,000) | (1,782,000) | (2,511,000) |
| Interest and other income, net | 1,435,000 | 69,000 | 2,867,000 | 85,000 |
| Loss before income taxes | (18,269,000) | (23,864,000) | (57,291,000) | (74,426,000) |
| Income tax provision | 213,000 | 33,000 | 300,000 | 80,000 |
| Net loss | $ (18,482,000) | $ (23,897,000) | $ (57,591,000) | $ (74,506,000) |
| Net loss per common share, basic (in USD per share) | $ (0.61) | $ (0.80) | $ (1.89) | $ (2.51) |
| Net loss per common share, diluted (in USD per share) | $ (0.61) | $ (0.80) | $ (1.89) | $ (2.51) |
| Weighted-average shares, basic (in shares) | 30,502 | 29,843 | 30,400 | 29,720 |
| Weighted-average shares, diluted (in shares) | 30,502 | 29,843 | 30,400 | 29,720 |
IRTC Balance Sheet
2023-06-30Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
|---|---|---|
| Current assets: | ||
| Cash and cash equivalents | $ 61,578 | $ 78,832 |
| Marketable securities | 103,161 | 134,312 |
| Accounts receivable, net | 51,108 | 49,918 |
| Inventory | 14,478 | 15,155 |
| Prepaid expenses and other current assets | 11,816 | 10,555 |
| Total current assets | 242,141 | 288,772 |
| Property and equipment, net | 89,845 | 75,670 |
| Operating lease right-of-use assets | 57,917 | 60,666 |
| Goodwill | 862 | 862 |
| Other assets | 38,723 | 22,252 |
| Total assets | 429,488 | 448,222 |
| Current liabilities: | ||
| Accounts payable | 7,150 | 7,517 |
| Accrued liabilities | 64,469 | 65,497 |
| Deferred revenue | 3,695 | 3,051 |
| Operating lease liabilities, current portion | 14,099 | 13,031 |
| Total current liabilities | 89,413 | 89,096 |
| Debt, noncurrent portion | 34,942 | 34,935 |
| Other noncurrent liabilities | 1,012 | 1,307 |
| Operating lease liabilities, noncurrent portion | 80,242 | 83,072 |
| Total liabilities | 205,609 | 208,410 |
| Commitments and contingencies (Note 8) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value - 5,000 shares authorized; none issued and outstanding at June 30, 2023 and December 31, 2022 | 0 | 0 |
| Common stock, $0.001 par value - 100,000 shares authorized; 30,550 shares at June 30, 2023 and 30,193 at December 31, 2022 issued and outstanding | 30 | 28 |
| Additional paid-in capital | 803,792 | 762,380 |
| Accumulated other comprehensive loss | (152) | (396) |
| Accumulated deficit | (579,791) | (522,200) |
| Total stockholders’ equity | 223,879 | 239,812 |
| Total liabilities and stockholders’ equity | $ 429,488 | $ 448,222 |
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.